These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 13498454)

  • 21. In vitro sensitivity of bacteria to novobiocin, bryamycin, oleandomycin, vancomycin, amphomycin, bacitracin, and synnematin B.
    REEDY RJ; SHAFFER CH
    Antibiot Annu; 1956-1957; ():483-5. PubMed ID: 13425423
    [No Abstract]   [Full Text] [Related]  

  • 22. [On some recent antibiotics].
    DAUCHY F
    Concours Med; 1962 Dec; 84():6999-7000. PubMed ID: 14025233
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotic resistance of enterococci and related bacteria in an urban wastewater treatment plant.
    Ferreira da Silva M; Tiago I; Veríssimo A; Boaventura RA; Nunes OC; Manaia CM
    FEMS Microbiol Ecol; 2006 Feb; 55(2):322-9. PubMed ID: 16420639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotics and experimental toxoplasmosis. II. Erythromycin, magnamycin, neomycin and tebezon in experimental toxoplasmosis.
    GRONROOS P
    Ann Med Exp Biol Fenn; 1954; 32(3):257-9. PubMed ID: 14377021
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of antibiotic resistance genes and virulence factors in faecal enterococci of wild animals in Portugal.
    Poeta P; Costa D; Sáenz Y; Klibi N; Ruiz-Larrea F; Rodrigues J; Torres C
    J Vet Med B Infect Dis Vet Public Health; 2005 Nov; 52(9):396-402. PubMed ID: 16283919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Status and drug resistance surveillance of enterococcus infection in patients with severe hepatitis].
    Wang XD; Jiang KQ; Zhu BH; Jin RJ; Zheng B; Chen YP
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):375-7. PubMed ID: 16732916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of vancomycin and high level aminoglycoside resistant enterococci among high-risk patients.
    Moaddab SR; Rafi A
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):849-54. PubMed ID: 15115099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of erythromycin, spiramycin and novobiocin in the treatment of acute amoebic dysentery.
    POWELL SJ; WILMOT AJ; ELSDONDEW R
    J Trop Med Hyg; 1958 Mar; 61(3):67-70. PubMed ID: 13514846
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An alarming problem in the therapy of infective endocarditis: the development of antibiotic-resistant strains].
    Enia F; Bella R; Mineo R; Mizio G; Reina G
    Ital Heart J Suppl; 2005 Mar; 6(3):121-7. PubMed ID: 15875497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surveillance study of vancomycin resistant enterococci in pediatric haematology and oncology patients].
    Taşdelen Fişgin N; Darka O; Fişgin T; Hepsert S; Coban AY; Elli M
    Mikrobiyol Bul; 2006 Jul; 40(3):245-50. PubMed ID: 17001854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research on the development of resistance of Proteus species to antibiotics in routine use from 1950 to 1958; the in vitro action of novobiocin, kanamycin, nitrofurantoin and sulfonamides].
    LUTZ A; WITZ MA; SCHAEFFER A
    Ann Inst Pasteur (Paris); 1958 Oct; 95(4):413-23. PubMed ID: 13583664
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental studies with oleandomycin and other antibiotics].
    FUST B; BOHNI E; ZBINDEN G; STUDER A
    Helv Med Acta; 1956 Dec; 23(6):714-41. PubMed ID: 13405326
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the action of some cytostatics on cells cultured in vitro].
    LENTI G; TORTAROLO E
    G Ital Chemioter; 1956; 3(3-4):229-36. PubMed ID: 13462170
    [No Abstract]   [Full Text] [Related]  

  • 38. [Magnamycin].
    VERROTTI IC
    Pediatria (Napoli); 1953; 61(9-10):827-30. PubMed ID: 13133474
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of the development of resistance of enterococci to usual antibiotics from 1950 to 1956; comparative action in vitro of erythromycin, magnamycin, spiramycin, novobiocin, oleandomycin and vancomycin. II].
    LUTZ A; HOFFERER MJ
    Ann Inst Pasteur (Paris); 1957 Dec; 93(6):705-18. PubMed ID: 13498454
    [No Abstract]   [Full Text] [Related]  

  • 40. Research on the evolution of resistance of enterococci to usual antibiotics from 1950 to 1956; compared in vitro action of erythromycine, magnamycin, spiramycin novobiocin, oleoandomycin and vancomycin. I.
    LUTZ A; HOFFERER MJ
    Ann Inst Pasteur (Paris); 1957 Nov; 93(5):616-23. PubMed ID: 13478928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.